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A B S T R A C T
The present study describes the complexation between curcumin (Cur) and a peptide mixture
(Pep). Pep was prepared by enzymatic hydrolysis of casein and used as an excipient for poorly
water-soluble Cur. An aqueous solution of Pep and an acetone solution of Cur were mixed
and lyophilized to obtain a white-yellow powder of the peptide and Cur complex (Cur-
Pep). The water dispersibility of Cur was enhanced by the complexation with Pep. Pep was
fractionated using ammonium sulfate precipitation and ultrafiltration to identify which pep-
tides preferentially interact with Cur. Relatively hydrophobic peptides with high molecular
weights (>5 kDa) were more effective in enhancing the water dispersibility of Cur than other
fractions. Cur-Pep dispersed under acidic and neutral conditions, at which amphoteric Pep
is positively or negatively charged. Cur-Pep exists as a hydrocolloid with particle size 160–
330 nm in aqueous media.
© 2016 Shenyang Pharmaceutical University. Production and hosting by Elsevier B.V. This
is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
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1. Introduction
Curcumin (1,7-bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-
3,5-dione, Cur, Fig. 1) is a polyphenol compound derived from
turmeric root (Curcuma longa) and has attracted attention as
a potential chemotherapeutic agent [1,2]. It has a wide range
of biological and pharmacological effects including antioxi-
dant, antitumor, anti-inflammatory, and anticancer properties
[3–5]. However, absorption of Cur in the gastrointestinal tract
is poor because it is not highly soluble [6]. Its maximum solu-
bility is reportedly 11 ng/ml in a pH 5.0 aqueous buffer [7].
Therefore, various techniques have been used to increase its
water solubility and/or water dispersibility and improve its oral
bioavailability [8–10].
Amphiphilic block copolymer micelles have been used as
vehicles for the solubilization and stabilization of Cur [11,12].
Cur has also been incorporated intomicellar aggregates of cross-
linked and random copolymers of N-isopropylacrylamide with
N-vinyl-2-pyrrolidone, and poly(ethyleneglycol)monoacrylate.
The resulting nanoparticles (about 50 nm in diameter) were dis-
persed in aqueous media [13]. Complex formation between Cur
and cyclodextrins (CDs) also increases the water solubility of
Cur [7,13]. The hydrolytic stability of Cur improved after
* Corresponding author. University of Miyazaki, 1-1 Gakuen Kibanadai Nishi, Miyazaki 889-2192, Japan. Tel.: +81 985 58 7321; fax: +81 985
58 7323.
E-mail address: oshimat@cc.miyazaki-u.ac.jp (T. Oshima).
http://dx.doi.org/10.1016/j.ajps.2016.05.001
1818-0876/© 2016 Shenyang Pharmaceutical University. Production and hosting by Elsevier B.V. This is an open access article under
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
a s i an j o u rna l o f p h a rma c eu t i c a l s c i e n c e s 1 1 ( 2 0 1 6 ) 6 3 1 – 6 4 0
Available online at www.sciencedirect.com
journal homepage: www.elsevier.com/ locate /a jps
HOSTED BY
ScienceDirect
complexation with CDs, but its photodecomposition rate in-
creased compared with a Cur solution in an organic solvent.
Formation of a 2:1 complex between β-CD and Cur has also
been reported [14].Water-soluble polymers are also used to in-
crease the water solubility of Cur [15], and binding with
polyvinylpyrrolidone [16] and hyaluronic acid [17] has also been
studied. Incorporation into an emulsion is also an effective way
to enhance the oral administration of Cur [18–20].
Casein micelles have also been developed as nanocarriers
for Cur [21–25]. Complex formation of Cur with a casein micelle
and its use for delivery to cancer cells was investigated [21].
The complex was analyzed using fluorescence spectroscopy
[21,26,27]. Encapsulation of Cur in a camel β-casein micelle has
also been studied [28], as well as the binding of curcumin to
αS1-casein, which was analyzed by fluorescence spectroscopy
and circular dichroism [29,30]. Recently, encapsulation of Cur
in casein by spray-drying has been developed [31]. Soy protein
isolate can also be used as a complexation agent for Cur to
improve its water solubility [32].
In the present study, a peptide mixture (Pep) was pre-
pared by enzymatic hydrolysis of casein, and was used as a
complexation agent for Cur. Recently, researchers have found
that peptide mixtures obtained as protein hydrolysate were ef-
fective in enhancing the water solubility and/or water
dispersibility of poorly water-soluble materials.The water solu-
bility of a poorly water-soluble drug, indomethacin, was
enhanced by complexation with Pep [33,34]. The resulting
complex between indomethacin and Pep is quite small and can
pass through ultrafilter membranes. Additionally, complex-
ation with albumin hydrolysate as a peptide mixture enhanced
the water dispersibility of extremely poorly water-soluble co-
enzyme Q10 [35]. The particle size of the complex between
coenzyme Q10 and albumin hydrolysate was 170–280 nm, sug-
gesting that the complex is present as a hydrocolloidal material
in aqueous media. Furthermore, the water dispersibility of
paclitaxel was also enhanced by the complexation with Pep
[36].
Peptide mixtures prepared from protein hydrolysate will
contain diverse peptides with different molecular weights and
amino acid sequences. Some of these exhibit affinity to poorly
water-soluble materials on the basis of various interactions,
such as hydrophobic and/or electrostatic interactions. For
example, heme-iron-enriched polypeptide (digested hemoglo-
bin, HIP), which is obtained by hydrolysis of hemoglobin using
protease and subsequent enrichment by ultrafiltration, is known
to be complex between poorly water-soluble heme iron and
peptide fragments [37–40]. As the peptidic fraction of hemo-
globin hydrolysate confers hydrophilicity to heme iron, HIP is
apparently soluble in aqueous media and is more readily
absorbed by the human body than heme iron alone [41].These
examples demonstrate that complexation with Pep could in-
crease the water solubility, and consequently the oral
bioavailability, of Cur. In this study, casein was used as the re-
source to prepare Pep as it is an edible protein. Additionally,
casein is a family of four phosphoproteins αS1-casein, αS2-
casein, β-casein, and κ-casein,which show different hydrophilic/
hydrophobic balances, resulting in diverse peptides [42,43].
Therefore, Pep was fractionated using ammonium sulfate pre-
cipitation followed by ultrafiltration in order to specify and use
the peptides that are effective for enhancing the water
dispersibility of Cur [36].
Pep was prepared by enzymatic hydrolysis of casein and
fractionated by precipitation using ammonium sulfate solu-
tion and ulfrafiltration [36]. The complex between Cur and
Pep was prepared by mixing an acetone solution of Cur and
an aqueous solution of Pep, followed by removal of acetone
in vacuo and lyophilization [33,35]. The water dispersibility of
Cur-Pep was compared with Cur alone and with other excipi-
ents. To estimate the structure of Cur-Pep in aqueous media,
an aqueous suspension of Cur-Pep was fractionated by cen-
trifugation followed by successive membrane filtrations. The
particle size of Cur-Pep and the distribution of Cur in the
fractions were analyzed. The zeta potential distribution of
Cur-Pep and Pep was also measured to evaluate the surface
charge of the materials. Cur-Pep was characterized using
scanning electron microscopy (SEM), differential scanning
calorimetry (DSC), and powder X-ray diffraction (XRD). The
results were used to determine how Cur is incorporated into
Cur-Pep.
2. Materials and methods
2.1. Materials
Cur, milk casein (Hammarsten grade), polyethylene glycol 4000
(PEG 4000, with average molecular weight 4000 g/mol),
α-cyclodextrin, methyl-β-cyclodextrin, γ-cyclodextrin, glucose,
and sucrose were purchased fromWako Pure Chemical Indus-
tries, Ltd. (Osaka, Japan). α-Chymotrypsin from bovine pancreas,
pepsin from porcine gastric mucosa, and pancreatin from
porcine pancreas were purchased from Sigma-Aldrich Japan
K.K. (Tokyo, Japan). All other reagents were analytical grade.
Disposable membrane filters (DISMIC®, pore size: 0.80 μm
(25CS080AN), 0.45 μm (25CS045AN), or 0.20 μm (25CS020AN))
made of cellulose acetate were purchased fromAdvantec Toyo
(Tokyo, Japan). The following ultrafiltration membranes made
of regenerated cellulose were purchased from Merck Milipore
(Billerica, MA, USA) and used for fractionation of the pep-
tides: Ultracel® 5 kDa,molecular weight cut-off of 5000; Ultracel®
3 kDa, molecular weight cut-off of 3000; and Ultracel® 1 kDa,
molecular weight cut-off of 1000.
2.2. Preparation and fractionation of Pep
Pep was prepared by enzymatic hydrolysis of casein accord-
ing to similar procedures described previously [31]. Casein (25 g)
was hydrated in distilled water (500 ml) and the pH was
Fig. 1 – Molecular structure of Cur.
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adjusted to 7.8 with 5 MNaOH using a pH controller (TOKOTDP-
51, Tokyo, Japan). Casein was enzymatically hydrolyzed by
adding α-chymotrypsin (125 mg) and calcium chloride dehy-
drate (1.5 g) with stirring (200 rpm) at 44 ± 1 °C. During the
enzymatic hydrolysis, the pH of the mixture was kept at 7.8
using the pH controller. After 6 h, the mixture was heated at
81 ± 2 °C for 5 min to deactivate the enzyme. After cooling, the
mixture was lyophilized to obtain casein hydrolysate (Pep) as
a white powder.The molecular weight distribution of Pep was
determined using gel filtration chromatography/high-
performance liquid chromatography (GFC–HPLC; Prominence
Isocratic System, Shimadzu, Kyoto, Japan). Isocratic HPLC was
performed using a Shimadzu LC-10ADvp pump unit (flow rate:
0.5 ml/min) together with Shimadzu InertsilWP300 Diol (5 μm,
250mm × 7.6 mm I.D.) and Inertsil Diol (5 μm, 250mm × 7.6 mm
I.D.) columns, and detection of ultraviolet (UV) absorption with
a Shimadzu SPD-10Avp UV–Vis detector at 230 nm.
Subsequently, Pep was fractionated by combining ammo-
nium sulfate precipitation and ultrafiltration as follows (Fig. 2)
[36]. Pep (15 g) was dissolved in distilled water (300 ml) in an
ice-water bath. The mixture was stirred for 30 min and then
centrifuged at 10,000 × g for 10 min at 4 °C. The supernatant
was treated with 34.2 g (19 wt%) ammonium sulfate and the
precipitate was recovered. The resultant supernatant was
treated with 28 wt% ammonium sulfate and the precipitate was
recovered. In a similar manner, precipitates were obtained by
adding 34 wt% and 40 wt% ammonium sulfate repeatedly. Each
precipitate obtained by ammonium sulfate precipitation was
dissolved again by adding distilled water, and the solution was
ultrafiltered using an ultrafiltration unit (600 cm3, UHP-90K,
Advantec Toyo) using an ultrafiltration membrane with a mo-
lecular weight cut-off of 5000 g/mol at 0.3 MPa until 90 vol%
of the filtrate had passed through the membrane.The retentate
was lyophilized to obtain a fraction of Pep, and the permeate
was successively ultrafiltered again using ultrafiltration mem-
branes with molecular weight cutoffs of 3000 g/mol and 1000 g/
mol. During the ultrafiltration, the pH of the mixture was kept
at 7.0 by adding small amounts of 5 M NaOH and 6 M HCl.The
retentate was also lyophilized to obtain a fraction of Pep. Finally,
fractions A–L containing different peptides were prepared.
2.3. Preparation of Cur-Pep and water dispersibility test
An acetone solution of Cur was prepared by dissolving Cur in
acetone at a concentration of 0.1 g/l. An aqueous solution of
Pep was prepared by dissolving 10 g/l of fractions A–L con-
taining different peptides in water. Equal volumes (200 μl) of
the aqueous and organic solutions were mixed in a stop-
pered polypropylene centrifuge tube and shaken using a
thermoshaker (Hangzhou Allsheng Instruments MSC-100, Zhe-
jiang, China) at 30 °C for 1 h.After removing the acetone in vacuo
using a centrifugal evaporator (Thermo Scientific Savant
SpeedVac SPD1010, MA, USA), the residue was lyophilized to
obtain Cur-Pep as a white-yellow powder [33–36].
To evaluate the water dispersibility of Cur-Pep, 1.0 ml of
10 mM sodium phosphate buffer at pH 6.8 was added to Cur-
Pep.The aqueous mixture was shaken at 1500 rpm at 30 °C for
1 h. After filtration of the aqueous mixture using a 0.80 μm
membrane filter, the apparent solubility of Cur was deter-
mined using a UV–Vis spectrophotometer (JASCOV-660,Tokyo,
Japan). As pure Cur is not soluble in aqueous media, the molar
extinction coefficient of Cur at 420 nm in acetone (ε,
5.84 × 104 μM−1 cm−1) was used to determine the concentration.
The effect of the quantity of excipient on the water
dispersibility of Cur was studied as follows. An acetone solu-
tion (200 μL) containing 0.1 g/l Cur and an aqueous solution
Fig. 2 – Flowchart for the fractionation of Pep by combining ammonium sulfate precipitation and ultrafiltration.
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(200 μl) containing different concentrations of Pep (fraction A,
0–20 g/l) were mixed and shaken at 1500 rpm at 30 °C for 1 h.
After removing the acetone in vacuo, the residue was lyophi-
lized to obtain Cur-Pep. In a similar manner, Cur solution
(0.1 g/l) and an aqueous solution of excipients (PEG4000,
α-cyclodextrin, methyl-β-cyclodextrin, γ-cyclodextrin, glucose
and sucrose, 0–20 g/l) were mixed to obtain the complexes
between Cur and excipients (Cur-PEG4000, Cur-αCD, Cur-
mβCD, Cur-γCD, Cur-Glu, and Cur-Suc), respectively.To determine
the water dispersibility of the Cur complexes, 1.0 ml of 10 mM
sodium phosphate buffer at pH 6.8 was added to the Cur
complex. After shaking at 30 °C for 1 h, the aqueous mixture
was filtered using 0.80 μmmembrane filter.The apparent solu-
bility of Cur was determined using HPLC (Shimadzu Prominence
High Pressure Gradient System).The HPLC analysis system was
based on gradient reverse-phase HPLC using a Shimadzu LC-
20AB unit as a pump (flow rate: 0.4 ml/min) together with a
C18 column (TSKgel-ODS-100Z, 3.0 × 150 mm, 3 μm) (TOSOH,
Tokyo, Japan), and detection of absorption with a Shimadzu
SPD-20A UV–Vis detector at 420 nm. The mobile phase con-
sisted of two components: (A) water with 2% acetic acid, and
(B) acetonitrile.
The effect of pH on the water dispersibility of Cur was
studied as follows. Cur-Pep was prepared in a similar manner
to that shown above by mixing an acetone solution (200 μl) con-
taining 0.1 g/l Cur and an aqueous solution (200 μl) containing
Pep (fraction A, 5.0 g/l). Additionally, a blank sample (Cur-
Blank) was prepared by mixing an acetone solution (200 μl)
containing 0.1 g/l Cur and an aqueous solution (200 μl) without
Pep, followed by lyophilization. Each sample was added to 1.0 ml
of 10 mM sodium phosphate buffer solution at pH 2–8 and
shaken at 30 °C for 1 h.The aqueous mixture was filtered using
a 0.80-μm membrane filter and the apparent solubility of Cur
was determined using HPLC. The pH of the filtrate was mea-
sured using a pH meter (DKK-TOA Co. HM-25R, Tokyo, Japan).
The effect of treatment of simulated digestive fluid using
pepsin and pancreatin on the water dispersibility of Cur was
also studied as follows [44,45]. Cur-Pep was prepared in a similar
manner to that shown above. Each sample was added to 0.50 ml
of hydrochloric acid (pH 2.0) containing 20 mg/l pepsin and
shaken at 37 °C for 1 h. Successively, to the mixture was added
0.50 ml of 50 mM sodium phosphate buffer solution at pH 7.6
containing 20 mg/l pancreatin and shaken at 37 °C for 1 h.The
aqueous mixture was filtered using a 0.45-μmmembrane filter,
and the apparent solubility of Cur was determined using a UV–
Vis spectrophotometer. Same procedure was conducted without
pepsin or pancreatin as a control sample.
2.4. Zeta potential of Cur-Pep
Cur-Pep was prepared in a similar manner to that shown above
by mixing an acetone solution (200 μl) containing 0.1 g/l Cur
and an aqueous solution (200 μl) containing Pep (fractionA, 5.0 g/
l). Cur-Pep or Pep was added to 1.2 ml of 10 mM sodium
phosphate buffer solution with pH of 2–8.The aqueous mixture
was shaken and filtered using a 0.80-μm membrane filter. The
pH of the filtrate was measured using a pH meter.The zeta po-
tential of the filtrate was measured using a dynamic light
scattering (DLS) particle size/zeta potential analyzer (Horiba
SZ-100, Kyoto, Japan).
2.5. Material distribution and particle size analysis for
Cur-Pep
Cur-Pep was prepared in a similar manner shown above by
mixing an acetone solution (200 μl) containing 0.1 g/l Cur
and an aqueous solution (200 μl) containing Pep (fraction A,
5.0 g/l). Cur-Pep (10 mg) was added to 10 ml of 10 mM phos-
phate buffer (pH 6.8) and the aqueous suspension was
fractionated by centrifugation and membrane filtration as
follows [31,33]. The Cur-Pep suspension was centrifuged at
5000 rpm for 5 min and the supernatant was analyzed as a cen-
trifuged sample, F1.The supernatant was filtered using a 0.80-
μm membrane filter to obtain the filtrate, F2. Filtration using
a 0.45-μm membrane filter followed by a 0.20-μm membrane
filter was performed to obtain fractions F3 and F4, respec-
tively. The concentration of Cur in fractions F1–F4 was
determined using HPLC. The particle size of Cur-Pep in frac-
tions F1–F4 wasmeasured using a dynamic light scattering (DLS)
particle size/zeta potential analyzer. The average particle size
from DLS for each sample was determined as an average of
more than four measurements.
2.6. Characterization of Cur-Pep
A reference mixture (abbreviated as Cur-Pep-R) was prepared
by mixing Cur (6.0 mg) and Pep (30 mg) in the dry state to study
the effect of the mixing method. Differential scanning calo-
rimetry (DSC) analysis for Cur, Cur-Pep-R, Cur-Pep, and Pep
(fraction A) was performed using a Shimadzu DTG-60/60H
thermal analyzer from 25 to 300 °C at a heating rate of 10 °C/
min under nitrogen.The crystal structures of powder samples
were also examined using XRD with Cu Kα radiation
(MAXima_X, XRD-7000, Shimadzu). Measurements were per-
formed at 40 kV and 40 mA. The 2θ angle was set from 1° to
70°, and the scanning rate was 2°/min. Cur, Pep, and Cur-Pep
were also examined using scanning electron microscopy (SEM)
(VE-8800, Keyence Co., Osaka, Japan).
3. Results and discussion
3.1. Water dispersibility of Cur-Pep
Pep was fractionated using ammonium sulfate precipitation
followed by ultrafiltration in order to identify peptides which
are effective for the complexation with Cur. Relatively hydro-
phobic peptides should precipitate under lower ammonium
sulfate concentration. Therefore, peptides can be fraction-
ated using different concentrations of ammonium sulfate on
the basis of their hydrophilic/hydrophobic balance. Addition-
ally, peptides were fractionated by molecular weight, using
different ultrafilters. From the GFC–HPLC analysis results, the
molecular weights of the major components were 1100, 2600,
7100, and 10,500 g/mol [33]. Twelve Pep fractions A–L were ob-
tained by the combination of ammonium sulfate precipitation
followed by ultrafiltration (Table 1): They should contain dif-
ferent peptides with different hydrophilic/hydrophobic balance
and molecular weight. Fig. 3 shows the apparent solubility of
Cur-Pep prepared using different fractions at pH 6.8. The
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apparent solubility of Cur was enhanced by complexation with
Pep, and the solubilities of Cur-Pep prepared using fractions
A, D, and G were higher than those prepared using other frac-
tions. In particular, the solubility of Cur-Pep prepared using
fraction A was the highest of all the complexes. Its apparent
solubility was 5.19 mg/l, which is at least 3.8 times higher than
those prepared using other fractions.
Recently, the molecular weight and sequence of major pep-
tides in each fraction were identified usingmatrix-assisted laser
desorption/ionization time-of-flight/time-of-flight mass spec-
trometer with “LIFT” technique (MALDI LIFT-TOF/TOF MS)
(Table 2) [36]. As shown in the grand average of hydropathicity
(GRAVY) of the identified peptides [46], relatively hydropho-
bic peptides are contained in fractions A, B, and D, which are
obtained as precipitate under lower ammonium sulfate con-
centration. In contrast, relatively hydrophilic peptides were
present in fractions G, H, I, J, K, and L. Dominant peaks of 1718.0
and 1881.0 m/z detected in relatively hydrophobic fractions A,
B, C, D, E, and F were assigned to be β-casein fragment 194–209
(β-CN f194–209) with the sequence QEPVLGPVRGPFPIIV and β-CN
f193–209 with the sequence YQEPVLGPVRGPFPIIV, respec-
tively.The result suggests that relatively hydrophobic peptides
with high molecular weights are effective in enhancing the
dispersibility of Cur.This is similar to the case of HIP, in which
hydrophobic interactions are thought to be mainly involved in
the complexation between heme iron and peptides [38,40]. In
contrast, relatively hydrophilic peptides with lower molecu-
lar weights are less effective for complexation with Cur. Based
on this result, fraction A was used as Pep in the subsequent
experiments.
The photograph in Fig. 4 shows the aqueous suspension of
Cur alone and Cur-Pep in 10 mM phosphate buffer (pH 6.8)
before and after filtration using a 0.80-μm membrane filter. As
the water solubility of Cur is quite low, Cur does not disperse
in the aqueous media at all and precipitates at the bottom of
sample tube. After filtration using a 0.80-μm membrane filter,
the filtrate of Cur was colorless. In contrast, Cur-Pep dis-
perses in aqueous media giving a yellow-white solution. After
filtration, the solution of Cur-Pep became clear but remained
yellow. Fig. 5 shows the effect of the quantity of excipients (Pep
(fraction A), PEG4000, α-cyclodextrin, methyl-β-cyclodextrin,
γ-cyclodextrin, glucose, and sucrose) on the apparent solubil-
ity of Cur at pH 6.8. As shown in the profile for Cur-Pep, the
apparent solubility of Cur increased as the quantity of Pep
was increased. Saccharides are effective excipients for the
Table 1 – Yields and abbreviations of Pep fractions obtained by the combination of ammonium sulfate precipitation and
ultrafiltration.
(NH4)2SO4
concentration
Ultrafiltration conditions
Mw >
5000
5000 >
Mw > 3000
3000 >
Mw > 1000
Upper line; Pep yield 19.5 [wt%] 319 [mg]
fraction A
290 [mg]
fraction B
207 [mg]
fraction C
28.1 [wt%] 1480 [mg]
fraction D
288 [mg]
fraction E
190 [mg]
fraction F
Lower line; abbreviation 35.9 [wt%] 2020 [mg]
fraction G
72 [mg]
fraction H
519 [mg]
fraction I
43.4 [wt%] 847 [mg]
fraction J
128 [mg]
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81 [mg]
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Fig. 3 – Apparent solubility of Cur-Pep prepared using
different fractions.
Table 2 – Sequences of peptides in fractions A–L and the GRAVY scores [36].
Sequence identified Observed Calculated β-casein
residues
αS1-casein
residues
GRAVY
score
Fraction
Y<QEPVLGPVRGPFPIIV 1718.0 1717.0 194–209 0.594 A-F
L<YQEPVLGPVRGPFPIIV 1881.0 1880.1 193–209 0.482 A-F
W<MHQPHQPLPPTVMFPPQSVL>S 2281.1 2280.2 144–163 −0.270 A
K<AVPYPQRDMPIQAF>L 1632.7 1631.8 177–190 −0.293 F
M<HQPHQPLPPTVMFPPQSVL>S 2150.0 2149.1 145–163 −0.384 A-C,F
Y<PQRDMPIQAF>L 1202.6 1201.6 181–190 −0.720 I,L
K<HKEMPFPKYPVEPF>T 1745.7 1744.9 106–119 −1.00 E,F,H,I
RPKHPIKHQGLPQEVLNENLL>R 2460.2 2459.4 1–21 −1.00 G
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preparation of amorphous pharmaceutical solids [47]; however,
the solubility of Cur-Glu and Cur-Suc did not increase.The solu-
bility of Cur-PEG4000 is also much lower than that of Cur-
Pep. Macrocyclic cyclodextrins are well-known complexing
agents for Cur, as Cur fits into their relatively hydrophobic cavity
[7,13–15]. However, the solubilities of Cur-mβCD and Cur-γCD
were lower than that of Cur-Pep. Only Cur-αCD showed higher
solubility than Cur-Pep at high concentrations. The proce-
dure for the preparation of the Cur complex may not be optimal
for cyclodextrins; however, Pep was more effective in enhanc-
ing the dispersibility of Cur than many of the cyclodextrins.
The effect of pH on the apparent solubility of Cur-Pep and
Cur-Blank is shown in Fig. 6. Cur is present as the stable bis-
keto form under acidic or neutral conditions. Under basic
conditions, Cur is deprotonated (pKa values = 7.75–7.80,
8.55, and 9.05) and degrades to ferulic acid (4-hydroxy-3-
methoxycinnamic acid) and feruloylmethane (4-hydroxy-3-
methoxycinnamoyl-methane) [48]. Therefore, solubility tests
were conducted at pH 2–8. Cur-Blank, which was prepared
without Pep, was insoluble under all pH conditions investi-
gated.The apparent solubilities of Cur-Pep aremuch higher than
those of Cur-Blank over the pH range tested. However, the
apparent solubility of Cur-Pep decreased around pH 4.The pH
dependency of the Cur-Pep solubility is similar to that of the
complex between peptides and coenzyme Q10, which is in-
soluble under weakly acidic conditions [35]. The decrease in
the apparent solubility of Cur-Pep could be due to the aggre-
gation of Cur-Pep at a pH around the isoelectric point.The water
solubility of HIP, which is a complex between heme iron and
peptide fragments, also shows a similar pH dependency. HIP
is soluble under strongly acidic or neutral conditions and in-
soluble under weakly acidic conditions because of the isoelectric
point [38,40].
The effect of treatment of simulated digestive fluid using
pepsin and pancreatin on the water dispersibility of Cur was
also studied. As the Pep should be hydrolyzed using prote-
ases, the apparent solubility of Cur-Pep after enzymatic
treatment was 36 % compared to that of a control sample
without pepsin or pancreatin.This result suggests that Pep can
be hydrolyzed and is safe when it is orally administered, while
the dispersibility of Cur-Pep decreases. However, a peptide
complex HIP is found to bemore readily absorbed by the human
body [41]. Clinical study for oral administration of Cur-Pep
should be conducted in future work.
Fig. 4 – Image of aqueous suspensions of Cur (left) and Cur-Pep (right) before and after filtration using a 0.80-μm
membrane filter.
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Fig. 5 – Effect of the quantity of excipient on the apparent
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3.2. Zeta potential of Cur-Pep
Fig. 7 shows the zeta potential of aqueous suspensions of Cur-
Pep and Pep as a function of pH. The zeta potentials of Cur-
Pep and Pep decreased as the pH increased and the profiles
closely match each other.The isoelectric points of Cur-Pep and
Pep are 4.18 and 4.17, respectively, demonstrating that Pep domi-
nates the surface charge of Cur-Pep.As Pep consists of a mixture
of peptides, it behaves as a mixture of amphoteric polyelec-
trolytes. The zeta potential of Cur-Pep supports the results
regarding pH dependency of the apparent solubility of Cur-
Pep shown in Fig. 6. As the zeta potential of Cur-Pep at pH 4.2
approaches zero, the dispersibility of Cur-Pep decreases because
of the aggregation of Cur-Pep. Thus, Cur-Pep disperses under
strongly acidic and neutral conditions, but precipitates under
weakly acidic conditions.
3.3. Material distribution and particle size analysis
of Cur-Pep
An aqueous suspension of Cur-Pep was fractionated by cen-
trifugation and filtration using membrane filters (Φ 0.80 μm,
0.45 μm, and 0.20 μm). Fig. 8 shows typical particle size distri-
butions of fractions F2–F4 of the aqueous suspensions of Cur-
Pep determined using DLS. The particle size of F1 could not
be recorded because the fraction contained larger particles.
The particle sizes for F2–F4 of Cur-Pep were polydisperse and
160–330 nm. Therefore, Cur-Pep is present as a colloidal ma-
terial with wide particle size distributions.
Table 3 summarizes the average particle size from DLS and
the concentration of Cur for the fractions of Cur-Pep. The dis-
tribution of Cur in each fraction was consistent with the average
particle size: The relative concentration of Cur in each frac-
tion compared with F1 decreased from 0.586 to 0.064, indicating
that the particles of Cur-Pep were gradually captured by fil-
tration using 0.80-μm, 0.45-μm, and 0.20-μmmembrane filters.
These results show that Cur-Pep exists as a hydrocolloidal ma-
terial in aqueous media with polydisperse particle size, and
the particle size is around 160–330 nm.The hydrocolloidal be-
havior of Cur-Pep is similar to that of the peptide complexes
containing coenzyme Q10 [35] and paclitaxel [36]. On the other
hand, the complex between Pep and indomethacin is not a hy-
drocolloidal material and is permeable through ultrafilter
membranes [33].
3.4. Characterization of Cur-Pep
Fig. 9 shows SEM micrographs of Cur, Pep, and Cur-Pep. The
morphology of Cur-Pep was similar to that of Pep. As the crys-
talline structure of Cur was not observed in Cur-Pep, Cur-Pep
was found to be a homogeneous material with its main body
based on that of Pep.
DSC and XRD of Cur-Pep were examined to study the crys-
tallinity of Cur in the complex [9,15,33]. Fig. 10 shows the DSC
thermograms of Cur, Cur-Pep-R, Cur-Pep, and Pep.The DSC ther-
mogram of Cur showed an endothermal peak at 184 °C, which
can be attributed to the melting point of Cur (183 °C). Cur-Pep-
R, which is a mixture of solid Pep and Cur (5:1, w/w), showed
a slight endothermic peak at 184 °C, indicating that a small
quantity of crystallized Cur is present. However, no endother-
mic peak between 170 and 190 °C was observed for Cur-Pep.
The XRD patterns of Cur, Cur-Pep-R, Cur-Pep, and Pep are shown
in Fig. 11. The XRD data for Cur show the presence of crystal-
line Cur [9,49]. As the XRD pattern of Cur-Pep-R can be
superimposed on that of Cur, this shows that Cur-Pep-R also
contains crystalline Cur. In contrast, no diffraction peak of Cur
was observed in the XRD pattern of Cur-Pep, which indicates
that the Cur in Cur-Pep is amorphous.The results suggest that
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Fig. 7 – Zeta potential of aqueous suspensions of Cur-Pep
and Pep as a function of pH.
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Fig. 8 – Particle size distribution of Cur-Pep in aqueous
media determined using dynamic light scattering (DLS).
Table 3 – Average particle size from dynamic light
scattering (DLS) and concentration of Cur for the
fractions of Cur-Pep.
Fraction DLS Concentration
Cumulant
diameter
[nm]
Mode
diameter
[nm]
Conc.
[mg/l]
Conc./
Conc.F1
F1 * * 7.83 1.000
F2 335 297 4.59 0.586
F3 243 205 1.75 0.223
F4 199 161 0.500 0.064
* No result was obtained.
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Cur in Cur-Pep is incorporated into the peptide matrix and is
not present as a crystalline structure.
4. Conclusion
A peptide mixture from casein hydrolysate (Pep) enhances the
water-dispersibility of curcumin by complexation. In particu-
lar, relatively hydrophobic peptides with highmolecular weights
act as an effective excipient in for Cur.The water dispersibility
of curcumin in weakly acidic and neutral conditions in-
creased after complexation with Pep. Mass distribution of
curcumin and particle analysis by DLS showed the complex
was present as a hydrocolloidal material. DSC thermograms
and XRD data showed curcumin was present in an amor-
phous state in the complex. Increased water dispersibility of
the complex would increase the oral bioavailability of poorly
water-soluble curcumin, and a clinical study on the absorp-
tion of curcumin in the human body should be conducted in
future. Complexation with Pep would enhance the photo-
chemical stability of curcumin, which should be studied in
future work.
Fig. 9 – Scanning electron micrographs of Cur (A), Pep (B),
and Cur-Pep (C) at 1000× magnification.
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Fig. 10 – Differential scanning calorimetry (DSC) curves for
Cur, Cur-Pep-R, Cur-Pep, and Pep.
Fig. 11 – X-ray diffraction patterns for Cur, Cur-Pep-R, Cur-
Pep, and Pep.
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